Potent Efficacy of Entecavir (BMS-200475) in a Duck Model of Hepatitis B Virus Replication

The ability of entecavir (ETV) to inhibit Duck hepatitis B virus (DHBV) infection in duck hepatocytes and ducklings was examined using lamivudine (3TC) as a comparator drug. ETV exhibited antiviral activity (50% effective concentration [EC(50)], 0.13 nM) in DHBV-infected duck hepatocytes that was >1...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Marion, Patricia L., Salazar, Felix H., Winters, Mark A., Colonno, Richard J.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2002
Assuntos:	Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC126982/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11751115/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.46.1.82-88.2002
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!